MetLife Total Assets decreased by 0.3% to $743.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.0%, from $688.32B to $743.21B. Over 5 years (FY 2020 to FY 2025), Total Assets shows relatively stable performance with a -1.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth in total assets typically mirrors the overall expansion of the business, provided it is accompanied by corresponding revenue growth.
The aggregate value of everything the company owns, including both short-term liquid resources and long-term physical an...
Used to compare the scale of operations across the industry; larger asset bases generally suggest a more dominant market presence.
total_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $773.25B | $761.66B | $759.71B | $724.28B | $662.89B | $650.10B | $666.61B | $674.27B | $677.28B | $652.12B | $687.58B | $677.58B | $675.75B | $704.98B | $677.46B | $688.32B | $702.47B | $719.73B | $745.17B | $743.21B |
| QoQ Change | — | -1.5% | -0.3% | -4.7% | -8.5% | -1.9% | +2.5% | +1.1% | +0.4% | -3.7% | +5.4% | -1.5% | -0.3% | +4.3% | -3.9% | +1.6% | +2.1% | +2.5% | +3.5% | -0.3% |
| YoY Change | — | — | — | — | -14.3% | -14.6% | -12.3% | -6.9% | +2.2% | +0.3% | +3.1% | +0.5% | -0.2% | +8.1% | -1.5% | +1.6% | +4.0% | +2.1% | +10.0% | +8.0% |
| Segment | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 |
|---|---|---|---|---|---|---|---|---|
| Asia | $150.13B | $152.90B | $150.78B | $145.62B | $157.21B | $154.30B | $151.70B | $162.53B |
| MetLife Holdings | $149.74B | $151.21B | $149.97B | $143.24B | $148.52B | $146.62B | $144.05B | $146.40B |
| Latin America | $63.81B | $69.15B | $70.05B | $63.31B | $69.18B | $66.14B | $66.53B | $73.42B |
| Group Benefits | — | — | — | — | $36.72B | $37.08B | $35.97B | $36.89B |
| Corporate & Other | — | — | — | — | — | — | $35.94B | $36.37B |
| EMEA | $16.77B | $17.46B | $17.65B | $17.35B | $18.60B | $18.74B | $18.85B | $19.65B |
| Corporate and Other | $33.60B | $31.35B | $39.12B | $38.04B | $38.78B | $37.41B | — | — |
| U.S. | $252.56B | $252.20B | $249.71B | $244.56B | — | — | — | — |
| Total | $666.61B | $674.27B | $677.28B | $652.12B | $687.58B | $677.58B | $675.75B | $704.98B |
Asia, Corporate & Other, Corporate and Other, EMEA, Group Benefits, Latin America, MetLife Holdings, U.S. were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.